Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...
Reexamination Certificate
2005-01-04
2005-01-04
Berch, Mark L. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Unsubstituted hydrocarbyl chain between the ring and the -c-...
C544S118000, C544S276000, C544S277000
Reexamination Certificate
active
06838559
ABSTRACT:
Purine phosphodiesterase 7 (PDE 7) inhibitors of the following formulaswherein R1, Z, Y and J are described herein, and analogs thereof are provided which are useful in treated T-cell mediated diseases. R2is defined by the following(a) heteroaryl, or heterocyclo, either of which may be optionally substituted with one to three groups T1, T2, T3;(b) aryl substituted with one to three groups T1, T2, T3provided that at least one of T1, T2, T3is other than H; or(c) aryl fused to a heteroaryl or heterocyclo ring wherein the combined ring system may be optionally substituted with one to three groups T1, T2, T3.
REFERENCES:
patent: 3936439 (1976-02-01), Marumoto et al.
patent: 5240938 (1993-08-01), Greenlee et al.
patent: 5290801 (1994-03-01), Higley et al.
patent: 5646155 (1997-07-01), Wright
patent: 5792868 (1998-08-01), Izawa et al.
patent: 5869468 (1999-02-01), Freeman
patent: 5889178 (1999-03-01), Gregson et al.
patent: 6414147 (2002-07-01), Currie et al.
patent: 6426337 (2002-07-01), Cox et al.
patent: 4008858 (1991-09-01), None
patent: 467207 (1992-01-01), None
patent: 513979 (1992-11-01), None
patent: 544445 (1993-06-01), None
patent: 617046 (1994-09-01), None
patent: 624372 (1994-11-01), None
patent: 728757 (1996-08-01), None
patent: 827960 (1998-03-01), None
patent: 532878 (1999-06-01), None
patent: 1043324 (2000-10-01), None
patent: 2276383 (1994-09-01), None
patent: 775798 (1995-03-01), None
patent: WO 9317021 (1993-09-01), None
patent: WO 9410171 (1994-05-01), None
patent: WO 9526734 (1995-10-01), None
patent: WO 9716452 (1997-05-01), None
patent: WO 9735539 (1997-10-01), None
patent: WO 9807725 (1998-02-01), None
patent: WO 0068230 (2000-11-01), None
Roberts, “Basic Principles of Organic Chemistry”, p. 99-100.*
“Basic Organic Nomenclature” http://www.shsu.edu/˜chm_bea/BON.doc downloaded from the internet Feb. 18, 2004.*
Crute, J. Med. Chem 38, 1820 (1995).*
Wright, J. Med Chem 30, 109-116, 1987.*
Gardner, Biochemical and Biophysical Research Communications 272, 186 (2000).*
Schow et al., Bioorganic & Medicinal Chemistry Letters, 7(21):2697-2702 (1997).
Moharram et al., Egypt. J. Pharm. Sci., 31 (1-4):487-494 (1990).
Vesely et al., Eur. J. Biochem., 224:771-786 (1994).
De Azevedo et al., Eur. J. Biochem., 243:518-526 (1997).
Letham et al., Phytochemistry, 17:2053-2057 (1978).
Parker et al., Phytochemistry, 25(2): 303-310 (1986).
Nakata A. et al., Clin. Exp. Immunol. 2002, vol. 128, pp. 460-466.
Barbosa Joseph
Leftheris Katerina
Pitts William J.
Roberge Jacques Y.
Vaccaro Wayne
Berch Mark L.
Bristol-Myers Squibb Co.
Duncan Laurelee A.
LandOfFree
Purine inhibitors of phosphodiesterase (PDE) 7 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purine inhibitors of phosphodiesterase (PDE) 7, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purine inhibitors of phosphodiesterase (PDE) 7 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3386280